首页> 外国专利> Method of in vitro from patients with splenic marginal zone diagnosis.

Method of in vitro from patients with splenic marginal zone diagnosis.

机译:方法由脾边缘区患者体外诊断。

摘要

Method of in vitro from patients with splenic marginal zone diagnosis. The present invention describes a method of in vitro diagnosis of SMZL based on the analysis of the expression of a series of localized in a very specific region deleted human chromosome 7 genes. The specific region deleted in patients with SMZL has been defined by using CGH arrays high affinity and is located at 7q22.1 between 99925039-101348479 bases, where the genes: TSC22D4, HRBL, LRCH4, MUC3, MUC12, SH2B2 , MUC17 and CUX1. Also in the present invention in vitro diagnostic kits of SMZL, comprising at least one probe that recognize the deleted region 7q22.1 or hybridize at least one of the nucleotide sequences of the genes described above.
机译:脾边缘区患者的体外方法的诊断。本发明基于对一系列位于非常特定区域中缺失的人类染色体7基因的表达的分析,描述了一种SMZL的体外诊断方法。通过使用高亲和力的CGH阵列定义了SMZL患者中缺失的特定区域,该区域位于99925039-101348479个碱基之间的7q22.1处,其中的基因为:TSC22D4,HRBL,LRCH4,MUC3,MUC12,SH2B2,MUC17 CUX1。同样在本发明的SMZL的体外诊断试剂盒中,该试剂盒包括至少一个识别缺失区域7q22.1或至少杂交的探针。上述基因的核苷酸序列之一。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号